# Marina Macchini

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/marina-macchini/

## Facts

| Field | Value |
| --- | --- |
| Citations | 2,650 |
| Field | Pancreatic and Hepatic Oncology Research |
| h-index | 19 |
| i10-index | 28 |
| Last Known Institution | Vita-Salute San Raffaele University |
| OpenAlex ID | https://openalex.org/A5085754158 |
| ORCID iD | 0000-0001-5395-0155 |
| Works | 202 |

## Researcher papers

- [Nerve Growth Factor Promotes Gastric Tumorigenesis through Aberrant Cholinergic Signaling](https://scholariq.org/papers/nerve-growth-factor-promotes-gastric-tumorigenesis-through-aberrant-cholinergic/)
- [β2 Adrenergic-Neurotrophin Feedforward Loop Promotes Pancreatic Cancer](https://scholariq.org/papers/2-adrenergic-neurotrophin-feedforward-loop-promotes-pancreatic-cancer/)
- [Cholinergic Signaling via Muscarinic Receptors Directly and Indirectly Suppresses Pancreatic Tumorigenesis and Cancer Stemness](https://scholariq.org/papers/cholinergic-signaling-via-muscarinic-receptors-directly-and-indirectly/)
- [Dclk1 Defines Quiescent Pancreatic Progenitors that Promote Injury-Induced Regeneration and Tumorigenesis](https://scholariq.org/papers/dclk1-defines-quiescent-pancreatic-progenitors-that-promote-injury-induced/)
- [β2 Adrenergic-Neurotrophin Feedforward Loop Promotes Pancreatic Cancer](https://scholariq.org/papers/2-adrenergic-neurotrophin-feedforward-loop-promotes-pancreatic-cancer-2/)
- [Interleukin-1β-induced pancreatitis promotes pancreatic ductal adenocarcinoma via B lymphocyte–mediated immune suppression](https://scholariq.org/papers/interleukin-1-induced-pancreatitis-promotes-pancreatic-ductal-adenocarcinoma-via/)
- [Nab-paclitaxel plus gemcitabine with or without capecitabine and cisplatin in metastatic pancreatic adenocarcinoma (PACT-19): a randomised phase 2 trial](https://scholariq.org/papers/nab-paclitaxel-plus-gemcitabine-with-or-without-capecitabine-and-cisplatin-in/)
- [EUS-guided gastroenterostomy for management of malignant gastric outlet obstruction: a prospective cohort study with matched comparison with enteral stenting](https://scholariq.org/papers/eus-guided-gastroenterostomy-for-management-of-malignant-gastric-outlet/)
- [Chemotherapy in elderly patients with pancreatic cancer: Efficacy, feasibility and future perspectives](https://scholariq.org/papers/chemotherapy-in-elderly-patients-with-pancreatic-cancer-efficacy-feasibility-and/)
- [A randomised phase 2 trial of nab-paclitaxel plus gemcitabine with or without capecitabine and cisplatin in locally advanced or borderline resectable pancreatic adenocarcinoma](https://scholariq.org/papers/a-randomised-phase-2-trial-of-nab-paclitaxel-plus-gemcitabine-with-or-without/)
- [Long-term outcomes of endoscopic ultrasound–guided gastroenterostomy: a prospective cohort study tracking symptom recurrence, reintervention timelines, and stent modifications over time](https://scholariq.org/papers/long-term-outcomes-of-endoscopic-ultrasound-guided-gastroenterostomy-a/)

## Researcher topics

- [Pancreatic and Hepatic Oncology Research](https://scholariq.org/topics/pancreatic-and-hepatic-oncology-research/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Advanced Breast Cancer Therapies](https://scholariq.org/topics/advanced-breast-cancer-therapies/)
- [Estrogen and related hormone effects](https://scholariq.org/topics/estrogen-and-related-hormone-effects/)
- [Cancer, Stress, Anesthesia, and Immune Response](https://scholariq.org/topics/cancer-stress-anesthesia-and-immune-response/)

## Researcher university

- [Vita-Salute San Raffaele University](https://scholariq.org/institutions/vita-salute-san-raffaele-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.